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http://dx.doi.org/10.1016/j.jds.2013.0Abstract Background/purpose: Progesterone and estrogen levels are elevated during preg-
nancy and play a role in maternal immune responses. In addition, unbalanced metabolism of
growth factors has been demonstrated in pregnancy tumors. Therefore, we aimed to investi-
gate the effect of progesterone and b-estradiol on vascular endothelial growth factor-A (VEGF-
A) and basic fibroblast growth factor (bFGF) messenger RNA (mRNA) expression in THP-1 mono-
cytes in response to Porphyromonas gingivalis lipopolysaccharide (LPS).
Materials and methods: THP-1 monocytes were incubated with progesterone, b-estradiol, or
LPS from Escherichia coli and P. gingivalis for up to 24 hours. The expression of VEGF-A and
bFGF was investigated using conventional reverse transcription polymerase chain reaction
(RT-PCR) and real-time RT-PCR. Cell growth was assessed using cell proliferation assay.
Results: We reported herein that progesterone, but not b-estradiol, increased VEGF-A mRNA
expression in THP-1 monocytes. Significantly, progesterone enhanced VEGF-A mRNA expression
in P. gingivalis LPS-treated monocytes in comparison with a treatment with P. gingivalis LPS
alone. However, neither b-estradiol nor progesterone had any effect on bFGF production at
mRNA levels.t of Preventive Dentistry, Faculty of Dentistry, Naresuan University, Amphor Meaung, Phitsanulok
(P. Jitprasertwong).
iation for Dental Sciences of the Republic of China. Published by Elsevier Taiwan LLC. All rights reserved.
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Progesterone enhances the expression of VEGF-A 359Conclusion: The enhancing effect of progesterone on VEGF-A mRNA expression may have a role
in the pathogenesis of pyogenic granuloma in pregnant women.
Copyright ª 2013, Association for Dental Sciences of the Republic of China. Published by Else-
vier Taiwan LLC. All rights reserved.Introduction
Pregnancy tumor is a term for pyogenic granuloma that
occurs on the gingival mucosa of pregnant women in
response primarily to local irritation or injury.1e3 Although
the clinical and histological characteristics of pregnancy
tumor are well documented,3 its etiology and pathogenesis
are not fully understood. Hormonal imbalance is thought to
be a major determinant that is responsible for the devel-
opment of gingival hyperreactive inflammatory re-
sponses.1,4 Indeed, it has been postulated that the
pathogenesis of pregnancy gingivitis is initiated by bacterial
biofilm and exacerbated by endogenous sex steroid hor-
mones.5 The levels of serum and salivary sex hormones such
as progesterone and estrogen are significantly increased
throughout the three trimesters of pregnancy.6,7 Clinical
studies have shown the biological link between increased
gingival inflammation during pregnancy and changes in the
local immune system.6,8e10 In 2013, Gursoy et al4 demon-
strated a positive association between increased levels of
salivary estrogen and the severity of gingival inflammation
during pregnancy. Progesterone and estrogen have been
shown to stimulate the production of prostaglandin E2
(PGE2)
11 but to inhibit the production of interleukin 1b (IL-
1b) from human peripheral monocytes.12 Another study
showed that estrogen reduced the expression of chemokine
CCL3 messenger RNA (mRNA) but increased the expression
of CCL5 by periodontal ligament cells.13 These data suggest
that alterations in hormone levels and host inflammatory
response as a result of pregnancy may lead to further dys-
regulation of immune-inflammatory responses in the
periodontium, causing periodontal inflammation.6,14,15
Histological studies have revealed that pyogenic granu-
loma is characterized by the upregulation of growth factors
such as vascular endothelial growth factor (VEGF) and basic
fibroblast growth factor (bFGF), suggesting that the un-
balanced/excessive production of growth factors may be
one mechanism that mediates the development of pyogenic
granuloma.1,16 In vitro, it has been shown that the female
sex hormone is a potential regulator in the production of
several growth factors such as VEGF, bFGF, and nerve
growth factor in different cell types.17e20 It is thus plausible
that the female sex hormone may modulate the response to
periodontal infection in terms of growth factor synthesis in
pregnancy-related pyogenic granuloma. Because Porphyr-
omonas gingivalis is a major bacterial species implicated in
many forms of gingival diseases, including pregnancy
gingivitis,21,22 the interaction between female sex hor-
mones and P. gingivalis may be fundamentally important in
the development of pregnancy-related pyogenic granu-
loma. In addition, only a few studies have demonstrated
the interacting role between sex hormones and oral bac-
teria such as P. gingivalis in the synthesis of growth factorsby different cells in gingival tissues.23,24 Therefore, the aim
of this study was to investigate the in vitro effect of es-
trogen and progesterone on the expression of VEGF-A and
bFGF at mRNA level in differentiated THP-1 monocytes
treated with P. gingivalis LPS.
Materials and methods
Materials
Progesterone (P7556), estrogen (b-Estradiol, E4389), and cell
culturemediawere purchased from Sigma-Aldrich (St. Louis,
MO, USA). All plasticware were purchased from (Nunc A/S,
Roskilde, Denmark). Vitamin D3 (1a, 25-dihydroxy-vitamin
D3) was purchased from Calbiochem (Merck Chemicals,
Gibbstown, NJ, USA). Ultrapure LPS from Escherichia coli
0111.B4 and ultrapure LPS from P. gingivaliswere purchased
from Invivogen (San Diego, CA, USA). Recombinant PGE2 was
purchased from R&D Systems (Minneapolis, MN, USA).
THP-1 monocytes cell culture and stimulation
THP-1 promonocytes were purchased from the Cell Line
Service (CLS, Eppelheim, Germany) and cultured in RPMI-
1640 medium supplemented with 10% fetal bovine serum,
2 mM L-glutamine, 100 U/mL penicillin, and 100 mg/mL
streptomycin at 37C and 5% CO2. Cells were maintained at
a density of 3e8  105 cells/mL and cell viability was
monitored using trypan blue exclusion, which was always >
95%. THP-1 cells have a promonocyte phenotype with low
levels of CD14 expression. Therefore, prior to use in stim-
ulation experiments we differentiated THP-1 promonocytes
to a monocyte phenotype by incubation with 0.1 mM vitamin
D3 (VitD3) for 48 hours, as previously reported.
25 It has
been shown that 100 ng/mL E. coli/P. gingivalis LPS is an
optimal concentration used in stimulation experiments25
and progesterone, b-estradiol, and PGE2 concentrations
used in experiments are chosen based on previous studies
applying a comparable experimental setup.11 Cells were
then stimulated with LPS from E. coli and P. gingivalis
(100 ng/mL), progesterone (10 ng/mL), b-estradiol (1 ng/
mL), or PGE2 (2.5 ng/mL) for 1 hour, 3 hours, and 24 hours.
RNA extraction and cDNA synthesis by reverse
transcription
Total RNA was isolated from culture cells using a commer-
cial RNA extraction kit (RNeasy Mini Kit, Qiagen, Dusseldorf,
Germany) according to the manufacturer’s instructions.
The total RNA concentration of each sample was measured
with a spectrophotometer (Nanodrop, Thermo Fisher, Wil-
mington, DE, USA) and then stored at e80C. An aliquot
360 P. Jitprasertwong et alcontaining 1.0 mg of total RNA was used for the reverse
transcription reaction, which was conducted using iScript
cDNA Synthesis kit (Bio-Rad, Hercules, CA, USA). Comple-
mentary DNA (cDNA) samples were then stored at 2e8C.
Conventional reverse transcriptase polymerase
chain reaction
The mRNA expression of VEGF-A and bFGF genes was
detected using a conventional polymerase chain reaction
(PCR) method. b2 microglobulin (b2M) was used as an in-
ternal control gene. All primers used for PCR analysis were
purchased from Intron Bio (Gyeonggi-do, Korea). The
primer sets specific for each gene and the PCR conditions
are summarized in Table 1. The PCR was performed using i-
Taq PCR Master mix (Intron Bio, Gyeonggi-do, Korea) with
2.0 mL of cDNA sample. PCR amplification was conducted
for 35 cycles and the products of the PCR were then
separated by 2% agarose gel electrophoresis, visualized
with ethidium bromide staining, and viewed under ultravi-
olet light.
Quantitative analyses for VEGF-A mRNA using real-
time reverse transcriptase polymerase chain
reaction
The quantification of VEGF-A mRNA levels was performed
using a LightCycler 480II detection system (Roche, Man-
nheim, Germany). Reaction mixtures for PCR (20 mL) were
prepared by mixing 1.0 mL of cDNA solution, LightCycler 480
SYBRGreen I Master (Roche, Mannheim, Germany), and
VEGF-A primers. The relative fold changes between stimu-
lations were calculated with the comparative Ct method
(2eddCt), using b2M mRNA as the reference gene.
Cell proliferation assay
The potential mitogenic or cytotoxic effects of hormones
and LPS onTHP-1monocyte cultureswere evaluatedwith the
Cell Titer 96 Cell Proliferation Assay (Promega, Madison, WI,
USA). The assay was carried out according to the manufac-
turer’s instructions. Briefly, THP-1 monocytes (1 105 cells/
well) were cultured in quadruplicate in a 96-well tissue
culture plate in a total volume of 100-mL culture medium
either in the absence or presence of the indicated concen-
tration of hormones or LPS for 6 hours. An eight-point stan-
dard curve of THP-1 monocytes with 2  106 cells/mL as the
highest standard was produced using a twofold dilutionTable 1 Primers used in the polymerase chain reaction express
Gene Primer sequence (50-30)
VEGF-A26 F eATGAACTTTCTGCTGTCTTGGGT
R eTGGCCTTGGTGAGGTTTGATCC
bFGF27 F eAGAGCGACCCTCACATCAAG
R eACTGCCCAGTTCGTTTCAGT
b2M F eACCCCCACTGAAAAAGATGA
R eCTTATGCACGCTTAACTATCseries in fresh cell culture medium. Twenty mL of Owen’s
reagent were added to each well and cells were incubated
for an additional 1 hour. After incubation, absorption was
measured at 460 nm on a spectrophotometer (Microplate
Fluorescence Reader, Bio-Rad). Cell numbers of samples
were calculated by linear standard curve fitting.
Statistical analysis
Results were expressed as mean  standard deviation from
three independent experiments. Statistical analysis of
real-time reverse transcriptase polymerase chain reaction
(RT-PCR) data was performed on DCt values28 using SPSS
version 17.0 software (SPSS Inc. Chicago, IL, USA). Shapiro-
Wilk testing for normal distribution and Levene testing for
homogeneity of variance were performed prior to analysis
of variance. The P values were corrected for multiple
comparisons with the Bonferroni-Holm method. A P value
of < 0.05 was considered significant.
Results
Effect of progesterone and b-estradiol on VEGF-A
mRNA expression in THP-1 monocytes
To examine the hypothesis that progesterone or b-estradiol
may increase the expression of growth factors in THP-1
monocytes, themRNA expression of two growth factors were
investigated by conventional RT-PCR. As shown in Fig. 1,
THP-1 monocytes constitutively expressed VEGF-A and bFGF
mRNA. Compared to controls, a distinct upregulation of
VEGF-AmRNA expression was detected after treatment with
PGE2 and progesterone for 1 hour and 3 hours as the intensity
of VEGF-A bands were enhanced by progesterone and PGE2
stimulation. In addition, a slight upregulation of VEGF-A
mRNA expression in b-estradiol and LPS-treated cells at 3-
hour stimulation was also observed. By contrast, there was
no clear change of bFGFmRNA expression in THP-1monocyte
treated with hormones or LPS as compared with controls.
Because the conventional PCR is only semiquantitative at
best, thequantification of VEGF-AmRNAexpressionwas then
performed using real-time PCR.
Real-time PCR for VEGF-A mRNA in THP-1
monocytes
To validate the findings from conventional RT-PCR, the
quantitative effect of progesterone, b-estradiol and P.ion analyses.
Annealing
temperature (C)
Product size (bp)
60 344
60 234
60 120
Figure 1 Effect of progesterone and b-estradiol on VEGF-A and bFGF mRNA expression in THP-1 monocytes. THP-1 monocytes
(4  106 cells) were cultured in the absence or presence of progesterone; Pr (10 ng/mL), b-estradiol; Es (1 ng/mL), LPS from
Escherichia coli and Porphyromonas gingivalis (100 ng/mL), or PGE2 (2.5 ng/mL) for 1e24 hours. Total RNA was isolated and the
mRNA expression of VEGF-A, bFGF, and b2M were analyzed by RT-PCR. Positive control was PGE2. Negative (e) control was H2O.
Shown are representative results of three independent experiments. b2M Z b2 microglobulin; bFGF Z basic fibroblast growth
factor; LPSZ lipopolysaccharide; mRNAZ messenger RNA; PGE2Z prostaglandin E2; RT-PCRZ reverse transcription polymerase
chain reaction; VEGF-A Z vascular endothelial growth factor-A.
Figure 2 VEGF-A and bFGF mRNA expression in THP-1 monocytes after stimulation with b-estradiol, progesterone, and Por-
phyromonas gingivalis LPS. (A,B) THP-1 monocytes (4  106 cells) were cultured in the absence or presence of progesterone; Pr
(10 ng/mL), b-estradiol; Es (1 ng/mL), PGE2 (2.5 ng/mL), and/or LPS from Escherichia coli and P. gingivalis (100 ng/mL) for 3 hours.
(C) THP-1 monocytes were stimulated with a combination of progesterone or b-estradiol and Porphyromonas gingivalis LPS for 3
hours, hormones or LPS alone served as controls. The amount of VEGF-A and bFGF mRNA was quantified by RT-PCR. The data are
expressed as mean of three independent experiments. * P < 0.05 compared with controls. bFGFZ basic fibroblast growth factor;
LPS Z lipopolysaccharide; mRNA Z messenger RNA; PGE2 Z prostaglandin E2; RT-PCR Z reverse transcription polymerase chain
reaction; VEGF-A Z vascular endothelial growth factor-A.
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determined by real-time PCR. Fig. 2 shows the results from
real-time PCR. Compared to controls, both progesterone
and PGE2 significantly upregulated VEGF-A mRNA expres-
sion (1.77- fold; P < 0.05 and 3.56-fold; P < 0.001
respectively) whereas treatment with b-estradiol or LPS
from E. coli and P. gingivalis alone did not alter the VEGF-A
mRNA level in THP-1 monocytes at 3-hour stimulation. The
expression of VEGF-A mRNA was close to 1 in b-estradiol
and LPS-treated cells indicating that there were no differ-
ences in VEGF-A mRNA expression in those cells compared
to controls. The results from real-time PCR also confirmed
the conventional RT-PCR data that bFGF mRNA is consti-
tutively expressed in THP-1 monocytes and remains un-
changed after stimulation either with female sex hormones
or with bacterial LPS (Fig. 2B). To investigate the role of b-
estradiol and progesterone on VEGF-A expression by THP-1
monocytes in response to P. gingivalis LPS, THP-1 mono-
cytes (0.5  106) were incubated with estrogen (1 ng/mL)
or progesterone (10 ng/mL) in the presence and absence of
LPS from P. gingivalis (100 ng/mL) for 3 hours. Unstimu-
lated cells and cells stimulated with hormones or LPS alone
served as controls. As shown in Fig. 2C, P. gingivalis LPS and
b-estradiol alone had no effect on VEGF-A mRNA expression
in THP-1 monocytes. Only progesterone stimulation
increased VEGF-A mRNA expression by 1.71-fold compared
to the control (P < 0.05). Interestingly, progesterone, but
not b-estradiol, significantly promoted VEGF-A mRNA
expression in P. gingivalis LPS-treated cells (P. gingivalis
LPS; 0.97-fold vs. progesterone plus P. gingivalis LPS 1.87-
fold, P < 0.05). Whether upregulation of VEGF-A mRNA
expression was due to mitogenic or cytotoxic effect of
progesterone on the viability of THP-1 monocytes was also
determined. After 6 hours of b-estradiol or progesterone
stimulation, no significant change in the cell number of
THP-1 monocytes was detected in comparison to theFigure 3 The effect of b-estradiol and progesterone on cell
proliferation in THP-1 monocytes. THP-1 monocytes (1  105
cells/well) were stimulated with b-estradiol; Es (1 ng/mL),
progesterone; Pr (10 ng/mL) or LPS from Escherichia coli and
Porphyromonas gingivalis (100 ng/mL). Cell proliferation was
analyzed with the Cell Titer 96 cell proliferation assay after 6
hours. The graph represents mean standard deviation (nZ 4).
* P < 0.05 compared with controls. LPSZ lipopolysaccharide.control (P > 0.05, Fig. 3). By contrast, cell numbers of THP-
1 monocytes stimulated with E. coli or P. gingivalis LPS
were significantly lower (P < 0.05) compared to the
control.Discussion
Because female sex hormones play a role in the patho-
genesis of pregnancy-associated gingival diseases,2,29 un-
derstanding the effect of estrogen and progesterone on
cellular immune responses may provide an insight in the
mechanistic link between pregnancy and periodontal dis-
eases. Although studies have demonstrated the proin-
flammatory roles of female sex hormones in pregnancy
gingivitis and pregnancy tumor,4,29,30 the underlying mo-
lecular mechanisms in this pathway are not fully under-
stood. The current study demonstrated that progesterone,
but not estradiol, increased VEGF-A mRNA expression in
THP-1 monocytes. In addition, progesterone significantly
enhanced VEGF-A mRNA expression in P. gingivalis LPS
treated monocytes in comparison with a treatment with P.
gingivalis LPS alone. However, we observed that either
estradiol or progesterone had little or no effect on bFGF
production at mRNA levels. These data may reflect that
although monocytes are suggested to be one of a major
source for bFGF, the regulation of this gene at transcrip-
tional levels may not be associated with the stimulation by
bacterial LPS and hormones in THP-1 monocytes. It is
therefore interesting to explore the transcriptional regu-
lation of bFGF in other possible cell types such as gingival
fibroblasts and macrophages.15
The results that progesterone enhances VEGF-A mRNA
expression in THP-1 monocytes support the concept that
female sex hormones modify the periodontal inflammation
and healing process during pregnancy. VEGF, a member of
the angiogenic factor family, plays a vital role in the pro-
cess of vascular formation.31 It has been suggested that
elevated levels of VEGF are associated with pathological
angiogenesis such as tumors, rheumatoid arthritis, and
diabetic retinopathy.31,32 Macrophages/monocytes are a
major source of VEGF.33 The known inducers for VEGF are
platelet-derived growth factor, phorbol esters, interleukin
(IL)-1b, and PGE2.
34,35 Similar to a previous study,34 we
found that PGE2 (which was a positive control) upregulated
VEGF-A mRNA expression in THP-1 monocytes. Estradiol
and progesterone have been reported to regulate the
production of several growth factors such as VEGF-A and
nerve growth factor in monocytes/macrophages.15,19,36 At
protein levels, estradiol and progesterone can stimulate
VEGF-A secretion by U937 monocytes15 and peritoneal
macrophages.37 In addition, Kanda and Watanabe36 found
that 17b-estradiol induced VEGF-A production at both
mRNA and protein levels in phorbol-12-myristate-13-
acetate (PMA)-differentiated THP-1 monocytes. However,
the current study demonstrated that only progesterone
significantly upregulated VEGF-A mRNA expression whereas
estradiol had no or very little effect on the VEGF-A mRNA
expression. These discrepancies may be explained at least
in part by the diverse immunological assay variations,
different concentrations of hormones, or different cell
differentiation techniques.38 Indeed, PMA-treated THP-1
Progesterone enhances the expression of VEGF-A 363monocytes in the previous study were differentiated into
macrophage-like cells36 whereas the current study used
VitD3 to differentiate THP-1 monocytes into mature
monocyte characteristics.
In response to LPS stimulation, female sex hormones
display an enhancing effect on cytokine or growth factor
production in various cell types. In human gingival fibro-
blasts, Yokoyama et al24 reported that estradiol increases
sensitivity to Campylobacter rectus-induced VEGF-A
secretion. In addition, progesterone has been shown to
enhance the production of IL-1b and IL-8, but to inhibit
TNF-a production by monocytes stimulated with E. coli
LPS.39 Moreover, progesterone promotes E. coli LPS-
induced VEGF-A secretion in U937 monocytes.15 Interest-
ingly, the current study demonstrated that treatment with
progesterone led to a significant increase in the P. gingivalis
LPS-stimulated expression of VEGF-A mRNA by THP-1
monocytes. These data suggest the proinflammatory role
of female sex hormones in cellular immune response to
bacterial LPS. In addition, the interaction between pro-
gesterone and P. gingivalis LPS may have a regulatory role
in the early pathological vascular changes in pregnancy
gingivitis.
The results from cell proliferation assay showed that
both estradiol and progesterone had no proliferative or
cytotoxic effects on THP-1 monocytes. Any progesterone-
induced changes in VEGF-A expression were therefore not
due to changes in cell numbers. However, it should be
noted that cell numbers of THP-1 monocyte stimulated with
LPS were significantly lower in comparison to the control,
indicating that LPS may have a cytotoxic effect on the THP-
1 monocytes at 6 hours. However, LPS-stimulation of THP-1
monocytes or stimulation with other proinflammatory
agents such as PMA induced cell differentiation and growth
cycle arrest. 40 Therefore, it is possible that the unstimu-
lated THP-1 monocytes continued to proliferate while LPS-
stimulated cells switched from proliferation to differenti-
ation. In addition, although cell numbers were lower after
LPS-stimulation in THP-1 monocytes in comparison to the
control, the remaining cell number was still comparable to
the starting cell number of the experimental setup. This
possibly indicates a decline in the proliferative capacity
rather than LPS-induced cell death. In conclusion, the
current study supports that progesterone modulates
cellular immune responses through growth factor upregu-
lation. The effect of progesterone on VEGF-A synthesis may
play a role in periodontal disease associated with
pregnancy.
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